Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis
Journal of Neurology, Neurosurgery & Psychiatry May 18, 2018
Rathbone E, et al. - Study authors assessed if the ratio of cerebrospinal fluid (CSF) immunoglobulin kappa to lambda light chains at the time of multiple sclerosis (MS) diagnosis predicts disease progression, and if this was inherent to CSF plasmablasts. They reported that CSF immunoglobulin κ:λ ratios, established at the time of diagnostic lumbar puncture, forecast MS disease progression and may, therefore, be helpful predictive markers for early therapeutic stratification.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries